Brinter, a MedTech platform company, develops the first-ever series of 3D bioprinted bio-synthetic implants for the $4B soft tissue repair market. S
Created: 2025-08-07
Updated: 2025-09-06
Company - Brinter
Product/Service
- Classification
- In-Space Manufacturing
- Category
- In-Space Manufacturing
- Fields
- Biotech
- Status
- Development
- First launch
- Not announced
Brinter AM to Launch 3D Bioprinter to the International Space Station, 2024-08-29.
- Brinter AM Technologies Oy has been selected to provide a 3D bioprinter for a European Space Agency (ESA) project aimed at advancing tissue manufacturing capabilities on the International Space Station (ISS).
- The Finnish company will supply its bioprinter, Brinter Core, to Redwire Space NV, which is spearheading the project to develop the 3D-BioSystem Facility under the ESA Exploration Programme.
- Brinter AM Technologies will adapt its Brinter Core bioprinter to meet the stringent requirements of space technology. The bioprinter will be integrated into the 3D-BioSystem Facility, which will operate in the ISS's Columbus module.